Restrictions on the use of published WikiLeaks material remain in effect in much of the government, the New York Times reported yesterday, causing considerable confusion and frustration. See “Detainees’ Lawyers Can’t Click on Leaked Documents” by Scott Shane, April 27.
“Add me to the list of grumblers,” said a respected national security analyst at the Congressional Research Service, where employees have been prohibited from accessing WikiLeaks documents online.
“This whole thing is so [expletive] stupid,” he said yesterday. “Even staff with clearances can’t read the cables, let alone quote them. One reason is that we can’t read classified materials on unclassified computers and we have no classified computers.”
“We can now quote news stories which cite the cables, but we have no way of verifying whether the article correctly quotes the cables.”
“This is hampering CRS work and management knows it,” the analyst said. “There’s just no leadership on this issue.”
As surrogate markers are increasingly being accepted by FDA to support approval of new drugs and biologics, it is imperative that patients and clinicians understand whether such novel endpoints are reflective of meaningful clinical benefits.
The Secretary of Health and Human Services should launch a Department-wide initiative to reduce wasteful spending on health services, drugs, and ineffective medical devices, saving many lives as well as billions of dollars annually.
Now that the One Big Beautiful Bill is law, the elimination of clean energy tax credits will cause a nation of higher energy bills – even for consumers and states that aren’t using clean energy.
Bureaucracy significantly hinders federally funded scientific research, diverting scientists’ time from discovery to low-value administrative tasks.